Premedications clinical trials

Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders

This study is looking into whether a drug called rituximab can help people with a rare nerve condition called anti-MAG neuropathy. Doctors want to see if it works for specific patients who might respond better, based on previous research.